Envoy Therapeutics in diabetes and obesity collaboration with Merck & Co
This article was originally published in Scrip
Executive Summary
Envoy Therapeutics has entered its first industry collaboration, a multi-year research programme with Merck & Co to discover novel diabetes and obesity drug targets.